全文获取类型
收费全文 | 1058篇 |
免费 | 80篇 |
国内免费 | 6篇 |
专业分类
儿科学 | 45篇 |
妇产科学 | 22篇 |
基础医学 | 110篇 |
口腔科学 | 12篇 |
临床医学 | 114篇 |
内科学 | 186篇 |
皮肤病学 | 17篇 |
神经病学 | 87篇 |
特种医学 | 41篇 |
外科学 | 52篇 |
综合类 | 19篇 |
预防医学 | 180篇 |
眼科学 | 12篇 |
药学 | 37篇 |
中国医学 | 1篇 |
肿瘤学 | 209篇 |
出版年
2022年 | 13篇 |
2021年 | 15篇 |
2020年 | 35篇 |
2019年 | 28篇 |
2018年 | 32篇 |
2017年 | 21篇 |
2016年 | 27篇 |
2015年 | 32篇 |
2014年 | 49篇 |
2013年 | 40篇 |
2012年 | 58篇 |
2011年 | 48篇 |
2010年 | 39篇 |
2009年 | 36篇 |
2008年 | 46篇 |
2007年 | 56篇 |
2006年 | 39篇 |
2005年 | 45篇 |
2004年 | 32篇 |
2003年 | 41篇 |
2002年 | 46篇 |
2001年 | 30篇 |
2000年 | 26篇 |
1999年 | 31篇 |
1998年 | 16篇 |
1997年 | 20篇 |
1996年 | 17篇 |
1995年 | 16篇 |
1994年 | 13篇 |
1993年 | 13篇 |
1992年 | 20篇 |
1991年 | 8篇 |
1990年 | 7篇 |
1989年 | 12篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 13篇 |
1985年 | 9篇 |
1984年 | 12篇 |
1983年 | 5篇 |
1980年 | 5篇 |
1979年 | 7篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1971年 | 8篇 |
1969年 | 9篇 |
1967年 | 5篇 |
1966年 | 3篇 |
排序方式: 共有1144条查询结果,搜索用时 62 毫秒
1.
2.
3.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
4.
5.
6.
7.
8.
9.
The use of item banks and computerized adaptive testing (CAT) begins with clear definitions of important outcomes, and references those definitions to specific questions gathered into large and well-studied pools, or “banks” of items. Items can be selected from the bank to form customized short scales, or can be administered in a sequence and length determined by a computer programmed for precision and clinical relevance. Although far from perfect, such item banks can form a common definition and understanding of human symptoms and functional problems such as fatigue, pain, depression, mobility, social function, sensory function, and many other health concepts that we can only measure by asking people directly. The support of the National Institutes of Health (NIH), as witnessed by its cooperative agreement with measurement experts through the NIH Roadmap Initiative known as PROMIS (www.nihpromis.org), is a big step in that direction. Our approach to item banking and CAT is practical; as focused on application as it is on science or theory. From a practical perspective, we frequently must decide whether to re-write and retest an item, add more items to fill gaps (often at the ceiling of the measure), re-test a bank after some modifications, or split up a bank into units that are more unidimensional, yet less clinically relevant or complete. These decisions are not easy, and yet they are rarely unforgiving. We encourage people to build practical tools that are capable of producing multiple short form measures and CAT administrations from common banks, and to further our understanding of these banks with various clinical populations and ages, so that with time the scores that emerge from these many activities begin to have not only a common metric and range, but a shared meaning and understanding across users. In this paper, we provide an overview of item banking and CAT, discuss our approach to item banking and its byproducts, describe testing options, discuss an example of CAT for fatigue, and discuss models for long term sustainability of an entity such as PROMIS. Some barriers to success include limitations in the methods themselves, controversies and disagreements across approaches, and end-user reluctance to move away from the familiar. 相似文献
10.
Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument 总被引:4,自引:0,他引:4
The revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life (QoL) instrument has been updated and expanded to provide more complete and accurate coverage of human immune deficiency virus/ acquired immune deficiency syndrome (HIV/AIDS)-related QoL. Factor analysis and the Rasch measurement model were used to determine a new subscale structure for the FAHI. The content of these subscales, including physical well-being (ten items, = 0.91), function and global well-being (13 items, = 0.86), emotional well-being/living with HIV (10 items, = 0.82), social well-being (eight items, = 0.73), and cognitive functioning (three items; = 0.75), reflect both general illness- and HIV/AIDS-specific QoL concerns: a total QoL score can also be calculated for the FAHI (44 items, =0.91). Psychometric evaluation revealed good internal consistency reliability for the FAHI and its subscales. In addition, construct validity, known groups validity and sensitivity to change were demonstrated by significant associations between the FAHI and additional indicators of functional status, psychological symptoms, stress and illness severity. In summary, the FAHI is a psychometrically sound instrument that captures multiple important dimensions of HIV/AIDS-related QoL. It is brief, easy to administer and score, has been translated into nine languages other than English and is appropriate for use in clinical trials and clinical practice. 相似文献